|
CYTH3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.895340E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.723820E-01 |
| Normal-vs-Stage2 |
2.237200E-04 |
| Normal-vs-Stage3 |
2.436500E-04 |
| Normal-vs-Stage4 |
4.023300E-04 |
| Stage1-vs-Stage2 |
7.198400E-03 |
| Stage1-vs-Stage3 |
1.919000E-03 |
| Stage1-vs-Stage4 |
4.320900E-03 |
| Stage2-vs-Stage3 |
5.805200E-01 |
| Stage2-vs-Stage4 |
8.714800E-01 |
| Stage3-vs-Stage4 |
7.015800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.595100E-03 |
| Normal-vs-AfricanAmerican |
1.939990E-01 |
| Normal-vs-Asian |
6.950000E-01 |
| Caucasian-vs-AfricanAmerican |
5.281200E-01 |
| Caucasian-vs-Asian |
1.685220E-01 |
| AfricanAmerican-vs-Asian |
4.214000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.769400E-04 |
| Normal-vs-Female |
3.112100E-02 |
| Male-vs-Female |
2.283600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.371600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.760000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.848100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.841300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.524600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.339220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.450200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.577900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.316200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.354600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.105800E-01 |
| Normal-vs-Grade 2 |
2.840600E-01 |
| Normal-vs-Grade 3 |
1.3517000000407E-06 |
| Normal-vs-Grade 4 |
2.097600E-03 |
| Grade 1-vs-Grade 2 |
2.075200E-01 |
| Grade 1-vs-Grade 3 |
7.756500E-04 |
| Grade 1-vs-Grade 4 |
1.685850E-02 |
| Grade 2-vs-Grade 3 |
3.30289999994626E-06 |
| Grade 2-vs-Grade 4 |
1.261790E-02 |
| Grade 3-vs-Grade 4 |
6.325000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.384800E-03 |
| Normal-vs-ccB subtype |
2.322000E-02 |
| ccA subtype-vs-ccB subtype |
7.693600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.042840E-03 |
| Normal-vs-N1 |
2.642000E-02 |
| N0-vs-N1 |
5.964800E-01 |
|
|
